Pharmaceutical Market Europe • December 2023 • 28-33

PMEA 2023

This year’s Awards, held at the Sheraton Park Lane in London, kicked off with a networking event and saw the arrival of hundreds of guests who were dressed in smart evening wear and excited to support their respective companies.

Being recognised through the PMEA programme is regarded as a significant achievement for those behind the initiatives and success can be a key driver for business growth, as well as for building morale with internal and external stakeholders.

This year’s Awards included 14 categories, which were carefully reviewed and updated in order to meaningfully demonstrate the ever-evolving medical and pharmaceutical landscapes.

Following a formal dinner, the Awards ceremony began with an opening speech from the night’s host, TV and radio presenter Jason Mohammad.

The first award of the evening recognised Excellence in Patient Education and Support and went to One Step Further – Resetting Expectations in hATTR Amyloidosis by Alnylam, with support from akt health. The judges noted that the entry had “deep insight into patient needs” and that they were particularly impressed by the perceptions into individual stories.

The Award for Patient-Centricity went to Recordati Rare Diseases for its entry titled #THISCUSHING – Global Awareness Campaign, Cushing Syndrome, which the panel said “succeeded in bringing emotion into an area often heavy with clinical data”.

The award recognising Excellence in Engagement through Integrated Channels was given to ‘KnowShingles’ – An Integrated Approach Empowering Older Adult Australians to Better Understand their Risk and the Impact of Shingles by GSK Australia, with support from Orchard. The judges described the entry as a “well-designed and brilliantly executed public health campaign that delivered some great results”.

Frontera Group’s entry titled JUST: Addressing Health Gender Gap won the award for Excellence in Public Health. The judges noted that it was a “relevant and attention-grabbing campaign that empowers the patient voice and raises awareness around a significant issue”, adding that they were “impressed with the reach and engagement achieved so far with limited resources and are excited to see what’s to come in terms of lasting behaviour change”.

Taking home the final award of the evening, the IPG Health Medical Communications Company of the Year, was Takeda UK and Ireland, which impressed the panel with its “tight-knit and unified” team. The company “demonstrated its evolution, was honest, competent and impressive,” the judges said.

The evening continued into the early hours with celebrations, dancing and networking, drawing another successful PMEA to a close.

This year’s host, Jason Mohammad

1. Excellence in Patient Education and Support – One Step Further – Resetting Expectations in hATTR Amyloidosis by Alnylam with support from akt health

2. Excellence in Healthcare Professional Education and Support Programmes – Open Horizons: An Educational Programme to Raise Standards of Care in Immune-Mediated Skin Diseases by AbbVie with support from Lucid Group Communications

3. Excellence in Collaboration and Partnerships – NHS, AstraZeneca, IQVIA lung cancer PATHFINDER Collaborative by AstraZeneca with support from IQVIA

4. Award for Patient-Centricity – #THISCUSHING – Global Awareness Campaign, Cushing Syndrome by Recordati Rare Diseases

5a. Excellence in Engagement through Digital Channels – A Novel Approach to Driving HCP Engagement and Measuring Meaningful Impact in Medical Education Developed independently by EPG Health through educational sponsorship from Pfizer

5b. Excellence in Engagement through Integrated Channels – ‘KnowShingles’ – An Integrated Approach Empowering Older Adult Australians to Better Understand their Risk and the Impact of Shingles by GSK Australia with support from Orchard

6. Excellence in Managing Established Products – The Fidaxomicin Story: Implementing Insights to Rejuvenate Brand Growth by Tillotts Pharma UK

7. Excellence in Rare Diseases or Orphan Drugs – Aiming For Zero in Hereditary Angioedema with Takhzyro by Takeda UK with support from Makara Health Communications

8. Excellence in Public Health – JUST: Addressing Health Gender Gap by Frontera Group

9.Excellence in Innovation – Virtual Lung Lab by Pfizer Inc with support from Synergy Medical Communications

10. Excellence in Capability Development – Dupixent Knowledge Challenge by Sanofi with support from Let’s Health

11. Excellence in Organisational Change Management or Transformation – Reshaping the Conversation for Gilead’s Established Products Portfolio by Gilead with support from OPEN Health

12 The Medscape Support Agency of the Year – Complete HealthVizion

Simon Bates, Group Head, welcomed everyone to the Awards evening

Rachel Harris from Page & Page and Partners

Paul Simpson from IQVIA UK

Caroline Gosling from Rubica